Adherence therapy for people with schizophrenia in Suanprung Psychiatric Hospital, Thailand: a randomised controlled trial

ISRCTN	ISRCTN74277581
DOI	https://doi.org/10.1186/ISRCTN74277581
Secondary identifying numbers	N/A

Prospectively registered

Protocol

Statistical analysis plan

Results

Individual participant data

Plain English summary of protocol

Not provided at time of registration

Dr Richard Gray
Scientific

P O Box 30
De Crespigny Park
Denmark Hill
London
SE5 8AF
United Kingdom

Phone	+44 (0)207 848 0139
Email	r.gray@iop.kcl.ac.uk

Study design	Randomised controlled trial
Primary study design	Interventional
Secondary study design	Randomised controlled trial
Study setting(s)	Hospital
Study type	Treatment
Scientific title	Adherence therapy for people with schizophrenia in Suanprung Psychiatric Hospital, Thailand: a randomised controlled trial
Study objectives	Adherence therapy can reduce symptoms, increase attitude and satisfaction towards medication treatment
Ethics approval(s)	Not provided at time of registration
Health condition(s) or problem(s) studied	Schizophrenia
Intervention	Treatment group: adherence therapy Control group: treatment as usual such as medication treatment, group counselling, occupational and recreational therapy
Intervention type	Other
Primary outcome measure	Symptoms of schizophrenia measured using the positive and negative syndrome scale
Secondary outcome measures	1. Symptoms of schizophrenia measured using the Global Assessment of Functioning Scale 2. Attitude towards medication measured using the Hogan Drug Attitude Inventory 3. Satisfaction with medication measured using the Satisfaction With Antipsychotic Medication Scale 4. Side effects of medication measured using the Liverpool University Neuroleptic Side Effect Rating Scale
Overall study start date	01/12/2004
Completion date	31/08/2005

Participant type(s)	Patient
Age group	Adult
Sex	Both
Target number of participants	70
Total final enrolment	32
Key inclusion criteria	1. Patients diagnosed by a psychiatrist with schizophrenia according to ICD-10 criteria (World Health Organisation ([WHO], 1992) 2. People with schizophrenia who are older than 20 years of age because they have reached the age of maturity legally and can provide consent independently 3. People with schizophrenia who have been assessed by a psychiatrist not involved in this study to determine that they can provide informed consent 4. People with schizophrenia who are residing in Muang Chiang Mai district
Key exclusion criteria	Patients suffering from organic brain diseases or learning disability
Date of first enrolment	01/12/2004
Date of final enrolment	31/08/2005

P O Box 30

London
SE5 8AF
United Kingdom

The Royal Thai Government
Government

Office of Educational Affairs
Royal Thai Embassy
28 Prince's Gate
London
SW7 1QF
Thailand

Government

Praboromarajanok Institute of Workforce Development (Thailand)

No information available

Intention to publish date
Individual participant data (IPD) Intention to share	No
IPD sharing plan summary	Not provided at time of registration
Publication and dissemination plan	Not provided at time of registration
IPD sharing plan

Output type	Details	Date created	Date added	Peer reviewed?	Patient-facing?
Results article	results	01/07/2007	31/05/2019	Yes	No

20/01/2020: Internal review.
31/05/2019: Publication reference and total final enrolment added.